Orientbio Inc. (002630)
Market Closed
11 Aug, 06:30
KRX SM KRX SM Primary ₩
1,057. 00
-7
-0.6579%
₩
80.51B Market Cap
- P/E Ratio
- Div Yield
21,195 Volume
- Eps
₩ 1,064
Previous Close Want to track 002630 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Orientbio Inc. (002630) Statistics
Valuation metrics
Market Cap 80.51B
Enterprise value 59.25B
Trailing P/E (ttm) -13.87
Forward P/E -
PEG ratio -0.14
Price/Sales (ttm) 2.12
Price/Book (mrq) 0.92
Enterprise Value/Revenue 1.99
Enterprise Value/EBITDA -28.48
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 785.94K
Average volume (90 days) 473.53K
Price summary
52-Week low 745
52-Week high 1,632
Beta -
50-Day moving average 907.37
200-Day moving average 667.36
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 0:1
Last split Date 21 Feb 2020
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.15%
Operating margin -0.15%
Operational effectiveness
Return on assets -0.06%
Return on equity -0.07%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 501.83
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -77.02
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 552.74
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 7.82%
Book value per share (mrq) 1,156.05
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
